HK1008825A1 - Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition - Google Patents

Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition

Info

Publication number
HK1008825A1
HK1008825A1 HK98109536A HK98109536A HK1008825A1 HK 1008825 A1 HK1008825 A1 HK 1008825A1 HK 98109536 A HK98109536 A HK 98109536A HK 98109536 A HK98109536 A HK 98109536A HK 1008825 A1 HK1008825 A1 HK 1008825A1
Authority
HK
Hong Kong
Prior art keywords
protein
purification
pharmaceutical composition
reagent kit
streptococcus
Prior art date
Application number
HK98109536A
Other languages
English (en)
Inventor
Gunnar Lindahl
Lars Stenberg
Margareth Stalhammar-Carlemalm
Original Assignee
Gunnar Lindahl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gunnar Lindahl filed Critical Gunnar Lindahl
Publication of HK1008825A1 publication Critical patent/HK1008825A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria
HK98109536A 1993-03-19 1998-07-29 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition HK1008825A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9300234 1993-03-19
PCT/SE1994/000246 WO1994021685A1 (en) 1993-03-19 1994-03-21 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition

Publications (1)

Publication Number Publication Date
HK1008825A1 true HK1008825A1 (en) 1999-05-21

Family

ID=20388669

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98109536A HK1008825A1 (en) 1993-03-19 1998-07-29 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition

Country Status (18)

Country Link
US (1) US5869064A (xx)
EP (1) EP0656014B1 (xx)
JP (1) JP3976334B2 (xx)
KR (1) KR100331358B1 (xx)
CN (1) CN1046291C (xx)
AT (1) ATE240351T1 (xx)
CA (1) CA2158658A1 (xx)
DE (1) DE69432658T2 (xx)
DK (1) DK0656014T3 (xx)
ES (1) ES2194024T3 (xx)
HK (1) HK1008825A1 (xx)
HU (1) HU217582B (xx)
NZ (1) NZ263275A (xx)
PT (1) PT656014E (xx)
SG (1) SG47049A1 (xx)
SI (1) SI0656014T1 (xx)
WO (1) WO1994021685A1 (xx)
ZA (1) ZA941958B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015889A (en) * 1993-03-19 2000-01-18 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
HU228497B1 (en) 1998-02-20 2013-03-28 Id Biomedical Corp Quebec Group b steptococcus antigens
PL201887B1 (pl) * 1998-12-22 2009-05-29 Microscience Ltd Peptyd, polinukleotyd kodujący ten peptyd, szczepionka, zastosowanie peptydu i polinukleotydu kodującego ten peptyd oraz przeciwciało
CZ20012174A3 (cs) 1998-12-22 2002-02-13 Microscience Limited Vnějąí povrchové proteiny, jejich geny a jejich pouľití
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
CA2356836C (en) * 1998-12-23 2011-09-13 Shire Biochem Inc. Novel streptococcus antigens
GB9910375D0 (en) 1999-05-05 1999-06-30 Lindahl Gunnar Vaccine composition
EP1795594A3 (en) * 2001-05-31 2008-04-02 Fuso Pharmaceutical Industries, Ltd. Method of evaluating the function of phagocyte and utilization thereof
JP3934605B2 (ja) * 2001-05-31 2007-06-20 扶桑薬品工業株式会社 感染症原因微生物の検出および同定のための改良された方法
JP2005535287A (ja) * 2002-02-11 2005-11-24 アイディー バイオメディカル コーポレイション グループｂ連鎖球菌抗原
US20070014841A1 (en) * 2005-02-08 2007-01-18 Denis Martin Pharmaceutical compositions
PT2144924T (pt) 2007-04-16 2016-08-17 Minervax Aps Vacina de proteína de fusão
CN108135992A (zh) 2015-10-21 2018-06-08 米纳瓦克斯有限责任公司 免疫原性融合蛋白
CA3004631A1 (en) 2015-12-30 2017-07-06 Minervax Aps Immunogenic complex for eliciting protective immunity against group b streptococcus
CA3066020A1 (en) 2017-06-16 2018-12-20 Glaxosmithkline Biologicals Sa Method of treatment
CA3161857A1 (en) 2019-11-22 2021-05-27 Glaxosmithkline Biologicals Sa Dosage and administration of a bacterial saccharide glycoconjugate vaccine
EP4066854A1 (en) 2021-03-29 2022-10-05 MinervaX Immunogenic fusion protein

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302386A (en) * 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US4772584A (en) * 1986-05-23 1988-09-20 Cleary Paul P Inhibitor of C5a-mediated chemotaxis
EP0367890A1 (en) * 1988-11-11 1990-05-16 HighTech Receptor AB Protein Arp, with immunoglobulin A binding activity, cloning and expression thereof
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
IL95578A (en) * 1989-09-15 1998-08-16 Gen Hospital Corp A vaccine made from polysaccharide and protein
WO1992017588A2 (en) * 1991-03-29 1992-10-15 Ervin Faulmann METHOD FOR PRODUCTION OF AN IgA BINDING PROTEIN DERIVED FROM GROUP B STREPTOCOCCI

Also Published As

Publication number Publication date
CN1119442A (zh) 1996-03-27
EP0656014B1 (en) 2003-05-14
JPH09500092A (ja) 1997-01-07
HU217582B (hu) 2000-02-28
DE69432658T2 (de) 2004-04-08
PT656014E (pt) 2003-09-30
SI0656014T1 (en) 2003-12-31
JP3976334B2 (ja) 2007-09-19
AU681130B2 (en) 1997-08-21
EP0656014A1 (en) 1995-06-07
WO1994021685A1 (en) 1994-09-29
KR960701096A (ko) 1996-02-24
SG47049A1 (en) 1998-03-20
NZ263275A (en) 1997-07-27
HUT72841A (en) 1996-05-28
AU6389194A (en) 1994-10-11
KR100331358B1 (ko) 2002-08-13
CA2158658A1 (en) 1994-09-29
DK0656014T3 (da) 2003-08-11
DE69432658D1 (de) 2003-06-18
US5869064A (en) 1999-02-09
CN1046291C (zh) 1999-11-10
ZA941958B (en) 1995-01-27
ES2194024T3 (es) 2003-11-16
HU9501993D0 (en) 1995-08-28
ATE240351T1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
HK1008825A1 (en) Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition
DE262192T1 (de) Verfahren und mittel zur herstellung eines proteins mit dergleichen igg-spezifizitaet wie protein g.
ES8504460A1 (es) Procedimiento para producir la totalidad o parte de las subunidades a y b de la toxina del colera
KR950032279A (ko) 인체의 프로그램된 세포 사멸과 관련 있는 펩티드 및 이를 암호하는 디엔에이(dna)
DE69735715D1 (de) Cholin-bindendes Protein, welches als gegen Pneumokokken gerichtetes Vakzin verwendet wird
AU1672388A (en) Expression of human proapolipoprotein a-i
MXPA03009294A (es) Proteinas de superficie de streptococcus pyogenes.
CA2123579A1 (en) Recombinant multivalent m protein vaccine
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
WO1998021337A3 (en) C3 BINDING PROTEIN OF $i(STREPTOCOCCUS PNEUMONIAE)
ZA933216B (en) Recombinant DNA molecules encoding aminopeptidas enzymes and their use in the preparation of vaccines against helminth infections
AU8127494A (en) Chimeric proteins comprising borrelia polypeptides: uses therefor
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
CA2093427A1 (en) Molecular clones of hiv-1 and uses thereof
AU7247891A (en) Purified myeloblastin, nucleic acid molecule encoding same, and uses thereof
AU2529095A (en) Vaccine against mycobacterial infections
WO1996008569A3 (en) Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
HUP0104825A2 (hu) Gének, fehérjék és alkalmazásuk
IT1260153B (it) Individuazione di un frammento di dna codificante l'enzima acido ialuronico sintetasi (has) e della sua sequenza nucleotidica
Schmidt et al. Mitogenicity of M5 protein extracted from Streptococcus pyogenes cells is due to streptococcal pyrogenic exotoxin C and mitogenic factor MF
BR9908476A (pt) Peptìdeo, composição terapêutica, e, processo para conferir imunidade protetora a um paciente, contra a infecção de s. pneumoniae
WO1997035982A3 (en) Monocyte chemotactic protein-5 materials and methods
NZ233672A (en) Alpha amylase-pullulanase enzyme produced by recombinant techniques and its dna coding sequence
AU1540795A (en) Diagnosis and treatment of infections due to streptococci and enterococci
AU6511986A (en) Recombinant ricin toxin

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110321